NAT10 Is Involved in Cardiac Remodeling Through ac4C-Mediated Transcriptomic Regulation
Circulation Research · 08.12.2023 · 133 (12) · 989-1002
DOI: 10.1161/circresaha.122.322244 ↗Kurz gefasst
Fachartikel in der Zeitschrift Circulation Research, erschienen am 08.12.2023. Verfasst von Jing Shi und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology (J.S., K.Z., J.Z., P.L., X.W., W.S., X.K.), The First Affiliated Hospital of Nanjing Medical University, Nanjing Medical Uni…. Hauptthemen laut MEDLINE: CD47 Antigen, Ventricular Remodeling. Die Arbeit wurde bisher 93-mal zitiert (Crossref) und nennt 61 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Heart failure, characterized by cardiac remodeling, is associated with abnormal epigenetic processes and aberrant gene expression. Here, we aimed to elucidate the effects and mechanisms of NAT10 (N-acetyltransferase 10)-mediated N4-acetylcytidine (ac4C) acetylation during cardiac remodeling. METHODS: NAT10 and ac4C expression were detected in both human and mouse subjects with cardiac remodeling through multiple assays. Subsequently, acetylated RNA immunoprecipitation and sequencing, thiol-linked alkylation for the metabolic sequencing of RNA (SLAM-seq), and ribosome sequencing (Ribo-seq) were employed to elucidate the role of ac4C-modified posttranscriptional regulation in cardiac remodeling. Additionally, functional experiments involving the overexpression or knockdown of NAT10 were conducted in mice models challenged with Ang II (angiotensin II) and transverse aortic constriction. RESULTS: NAT10 expression and RNA ac4C levels were increased in in vitro and in vivo cardiac remodeling models, as well as in patients with cardiac hypertrophy. Silencing and inhibiting NAT10 attenuated Ang II-induced cardiomyocyte hypertrophy and cardiofibroblast activation. Next-generation sequencing revealed ac4C changes in both mice and humans with cardiac hypertrophy were associated with changes in global mRNA abundance, stability, and translation efficiency. Mechanistically, NAT10 could enhance the stability and translation efficiency of CD47 and ROCK2 transcripts by upregulating their mRNA ac4C modification, thereby resulting in an increase in their protein expression during cardiac remodeling. Furthermore, the administration of Remodelin, a NAT10 inhibitor, has been shown to prevent cardiac functional impairments in mice subjected to transverse aortic constriction by suppressing cardiac fibrosis, hypertrophy, and inflammatory responses, while also regulating the expression levels of CD47 and ROCK2 (Rho associated coiled-coil containing protein kinase 2). CONCLUSIONS: Therefore, our data suggest that modulating epitranscriptomic processes, such as ac4C acetylation through NAT10, may be a promising therapeutic target against cardiac remodeling.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology (J.S., K.Z., J.Z., P.L., X.W., W.S., X.K.), The First Affiliated Hospital of Nanjing Medical University, Nanjing Medical University, China.
- Department of Cardiology, Yangpu Hospital, Tongji University School of Medicine, Shanghai, China (C.Y.).
- Department of Cardio-Thoracic Surgery, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing University, Jiangsu, China (C.K.).
- Department of Cardiovascular Surgery (H.S., R.Z.), The First Affiliated Hospital of Nanjing Medical University, Nanjing Medical University, China.
- Changzhou Medical Center of the Affiliated Changzhou No.2 People's Hospital of Nanjing Medical University and Department of Cardiology of the First Affiliated Hospital of Nanjing Medical University, Nanjing Medical Univ…
- Cardiovascular Research Center, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Gusu School, Nanjing Medical University, Suzhou, China (X.K.).
ORCID-Profile: Jing Shi, Chuanxi Yang, Peng Li, Haoliang Sun, Lianmin Chen
Zitieren
APA
Shi, J., Yang, C., Zhang, J., Zhao, K., Li, P., Kong, C., Wu, X., Sun, H., Zheng, R., Sun, W., Chen, L., & Kong, X. (2023). NAT10 Is Involved in Cardiac Remodeling Through ac4C-Mediated Transcriptomic Regulation. Circulation Research, 133(12), 989-1002. https://doi.org/10.1161/circresaha.122.322244
Vancouver
Shi J, Yang C, Zhang J, Zhao K, Li P, Kong C, et al. NAT10 Is Involved in Cardiac Remodeling Through ac4C-Mediated Transcriptomic Regulation. Circulation Research. 2023;133(12):989-1002. doi:10.1161/circresaha.122.322244
BibTeX
@article{Shi2023,
author = {Shi, Jing and Yang, Chuanxi and Zhang, Jing and Zhao, Kun and Li, Peng and Kong, Chuiyu and Wu, Xiaoguang and Sun, Haoliang and Zheng, Rui and Sun, Wei and Chen, Lianmin and Kong, Xiangqing},
title = {NAT10 Is Involved in Cardiac Remodeling Through ac4C-Mediated Transcriptomic Regulation},
journal = {Circulation Research},
year = {2023},
volume = {133},
number = {12},
pages = {989--1002},
doi = {10.1161/circresaha.122.322244}
}
EUVIMED